Vascular Flow

Dundee, United Kingdom Founded: 1998 • Age: 28 yrs
Vascular devices are developed using spiral laminar flow technology.

About Vascular Flow

Vascular Flow is a company based in Dundee (United Kingdom) founded in 1998. Vascular Flow has raised $16.79 million across 14 funding rounds from investors including NHS Choices, Scottish Enterprise and 3i Group. The company has 10 employees. Vascular Flow offers products and services including Spiral Laminar Flow Technology, Medical Device Development, and Contract Manufacturing. Vascular Flow operates in a competitive market with competitors including Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.

  • Headquarter Dundee, United Kingdom
  • Employees 10
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website vascular-flow.com
  • Social LinkedIn X
  • Legal Name Vascular Flow Technologies Limited
  • Date of Incorporation 08 Oct, 1998
  • Jurisdiction DUNDEE, SCOTLAND
Key Metrics
  • Annual Revenue
    $206.45 K (USD)
    22
    as on Dec 31, 2018
  • Net Profit
    -$944.89 K (USD)
    0
    as on Dec 31, 2021
  • Total Equity Funding
    $16.79M (USD)

    in 14 rounds

  • Investors
  • Employee Count
    10

Products & Services of Vascular Flow

Vascular Flow offers a comprehensive portfolio of products and services, including Spiral Laminar Flow Technology, Medical Device Development, and Contract Manufacturing.

Spiral Laminar Flow Technology
Medical Technology

Technology that restores natural blood flow in cardiovascular devices.

Medical Device Development
R&D Services

Services for developing cardiovascular devices from concept to market.

Contract Manufacturing
Manufacturing Services

Assembly and packaging of medical devices in ISO Class 7 cleanrooms.

Funding Insights of Vascular Flow

Vascular Flow has successfully raised a total of $16.79M across 14 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $16.79M
  • Total Rounds 14
  • Investors Count 8

Latest 10 of 14 funding rounds of Vascular Flow with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2019–Grant––
Jan 2016$4.29MSeries B––
–
Jan 2016$10.02MDebt – Conventional––
–
Dec 2015$4.45MSeries B––
–
Feb 2015$56,042Grant––
Oct 2014$63,090Grant––
Nov 2013$3.51MGrant––
–
Dec 2010$473,631Series A––
Mar 2010$746,995Series A––
Jan 2009$1.74MSeries A––
Valuation history

8 investors in total: 8 institutional.

Investors in Vascular Flow

Vascular Flow has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include NHS Choices, Scottish Enterprise and 3i Group.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
–eicfund.euBrussels, Belgium
Private equity investment firm
1997braveheartgroup.co.ukBarnsley, United Kingdom
Private equity firm focused on mid-market businesses
19453i.comLondon, United Kingdom
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Business development and leadership training programs are offered to companies.
1991scottish-enterprise.comGlasgow, United Kingdom
Corporate and M&A advisory services are provided across multiple sectors.
1974quaylemunro.comLondon, United Kingdom
NatWest Group is recognized as a UK-focused banking institution.
–rbs.comEdinburgh, United Kingdom
Provider of multiple healthcare services for patients
1948nhs.ukLondon, United Kingdom
Premium access

Investor details for Vascular Flow

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Vascular Flow

2 people are tracked at Vascular Flow (2 in leadership); the tracked headcount is 10.

NameRoleGroup
Bill Allan
CEO and Non-executive DirectorLeadership
Randall Black
Vice President Of SalesLeadership
Premium access

Complete people profiles for Vascular Flow

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Vascular Flow

3 dated milestones of Vascular Flow across 21 years, from founding to its latest funding, stage changes and deals.

  1. Founded Vascular Flow is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant,.

Competitors of Vascular Flow

Vascular Flow operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
csi360.com1989Saint Paul, United States$121.34M780
Devices for treating peripheral and coronary vascular disease are developed.
contegomedical.com2005Raleigh, United States$66.01M–
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
angioscore.com2003Fremont, United States$87M–
Scoring balloon catheters for coronary and peripheral angioplasty are developed.
echopointmedical.com2018London, United Kingdom$9.74M8
Smart devices for monitoring coronary artery disease are developed.
shapemem.com2009Santa Clara, United States$77.27M37
Embolization devices are developed using Shape Memory Polymer foams.
limflow.com2012Paris, France$97.45M–
Developer a system for venous arterialization of the lower limbs
terumo.com1921Somerset, United States––
Portfolio of medical devices for interventional cardiology is provided.
vasc.com1997Minneapolis, United States$12M562
Products for vascular diagnostics and interventional procedures are developed.
ev3.net2000Plymouth, United States$58.8M1,307
Surgical products for treatment of Peripheral vascular & Neurovascular diseases
relisysmedicaldevices.org1997Ranga Reddy, India$23.63M250
Medical devices for cardiovascular and structural heart treatments are supplied.
Premium access

Detailed competitors of Vascular Flow

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Vascular Flow

Premium access

Complete news archive for Vascular Flow

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Vascular Flow

10 companies that operate in the same segment as Vascular Flow (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Connected devices for health, sleep, and activity monitoring are developed.
2008Moulineaux, Seine-maritime, FranceUSD 93.83 M––
SMT is recognized as a developer of cardiovascular medical devices.
1998Surat, Gujarat, IndiaUSD 57.22 MUSD 106.25 M1,090
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M–255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
2006San Francisco, California, United StatesUSD 109.23 MUSD 747.14 M2,000
Provider of neuroprotection devices for carotid artery disease
2007Sunnyvale, California, United StatesUSD 241.8 M––
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
2007East Peoria, Illinois, United StatesUSD 154.77 M–104
Access catheters for neurovascular stroke treatment are provided.
2015Campbell, California, United StatesUSD 596 M––
Biosensor patches are developed for monitoring multiple body vitals.
2011Campbell, California, United StatesUSD 239.95 M–184
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Vascular Flow

Vascular Flow was founded in 1998 and raised its 1st funding round 3 years after it was founded.

Vascular Flow is headquartered in Dundee, United Kingdom. It is registered at Dundee, Scotland, United Kingdom.

Vascular Flow is a funded company, having raised a total of $16.79M across 14 funding rounds to date. The company's 1st funding round was a Series A of $1.74M, raised on Jun 2001.

Vascular Flow has 10 employees.

Annual revenue of Vascular Flow is $206.45K as on Dec 31, 2018.

Vascular Flow was founded in 1998 in Dundee, United Kingdom, within the medical devices sector focused on vascular implants. Spiral Laminar Flow technology has been developed to restore natural blood flow patterns in prosthetic grafts, enhancing patency and addressing disease progression. Applications encompass the Spiral Flow peripheral bypass graft and the Spiral Flow arteriovenous access graft for hemodialysis support. Operations center on research and device production for clinical use.

Vascular Flow's top competitors include Contego Medical, Limflow and Shape Memory Medical.

Vascular Flow offers Spiral Laminar Flow Technology, Medical Device Development, and Contract Manufacturing.

Vascular Flow has 8 investors. Key investors include NHS Choices, Scottish Enterprise, 3i Group, European Union, and Braveheart Investment Group.

Vascular Flow operates through Vascular Flow Technologies Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available